CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Stephen MacMillan

Chairman, Chief Executive Officer & President, Hologic

Search every verified Stephen MacMillan interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Stephen MacMillan, chairman, CEO, and president of Hologic, has been discussing the company's use of artificial intelligence in women's health diagnostics. In January 2025, he appeared on Fox Business to discuss the fourth annual Hologic Global Women's Health Index, which reported a decline in cancer testing rates. He described AI as having a "incredible impact on healthcare," citing its role in breast cancer detection and digital cytology, where it helps radiologists focus on key areas of images. He also referenced a $500 billion U.S. AI investment announced by President Trump, calling the government's support of industry "an incredibly important point." In October 2024, MacMillan discussed Hologic's acquisition of Gynesonics, a privately held medical device company, for approximately $350 million. He said the company's incisionless technology for treating uterine fibroids could reduce the need for hysterectomies, noting that about 77% of women experience fibroids during childbearing years. He also highlighted AI's benefits in mammography, stating that Hologic's AI detection catches one additional cancer for every ten detected by human radiologists and reduces false positives by 70%. MacMillan has emphasized the importance of early cancer detection, noting that many women delayed screenings during the COVID-19 pandemic, and has said the company aims to continue delivering EPS growth of over 10% annually.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →